We’re pleased to share the latest Editor’s Pick collection from RSC Pharmaceutics, selected by Editorial Board Member Professor Arvind Kumar Bansal. This collection brings together six articles that highlight recent advances in drug delivery, pharmaceutical technologies and nanomedicine.
Professor Bansal is Dean and Professor in the Department of Pharmaceutics at the National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, India. Reflecting on his selection, he commented:
“We are pleased to present a collection of impactful articles that captures the evolving landscape of drug delivery research, bringing together researchers from different regions of the globe.”
Explore the articles in Arvind Kumar Bansal’s Editor’s Pick collection:
Implementation-focused evaluation of transmission low-frequency Raman spectroscopy parameters for non-destructive quality control of solid dosage forms
Reo Kasahara, Motoki Inoue, Toshiro Fukami
RSC Pharm. 2026, 3, 441–448
Multiscale computational insights into 5-fluorouracil delivery via zeolite imidazole frameworks (ZIFs)
Michalis Vlachos, Giorgio Turtù, Marco Severi, Emmanuel Tylianakis, Emmanuel Klontzas, Francesco Zerbetto, George Froudakis
RSC Pharm. 2025, 2, 1479–1488
Polybasic nanogels for intracellular co-delivery of paclitaxel and carboplatin: a novel approach to ovarian cancer therapy
Angela M. Wagner, Olivia L. Lanier, Ani Savk, Nicholas A. Peppas
RSC Pharm. 2025, 2, 553–569.
Effect of shape on cellular internalization and anti-cancer efficacy of hydroxyapatite nanoparticles in an osteosarcoma cell line
Simmi Gupta, Esha S. Attar, Vishvesh Joshi, Padma V. Devarajan
RSC Pharm. 2025; 2, 1087–1095
Development of solid drug nanoparticle dispersions for pulmonary delivery of niclosamide and nitazoxanide via vibrating mesh nebulisation
Catherine Unsworth, Andrew B. Dwyer, Alison C. Savage, James J. Hobson, Jonathan Massam, Tom O. McDonald, Paul Curley, Andrew Owen, Andrew O’Sullivan, Ronan MacLoughlin, Steve P. Rannard
RSC Pharm. 2025, 2, 517–526
Polymeric nano-in-microparticles for pulmonary delivery of remdesivir against SARS-CoV-2
Alison Tatiana Madrid Sani, Brenno da Cunha Lima, Beatriz Moreira Rodrigues, Michelle Alvares Sarcinelli, Marcelo Henrique da Cunha Chaves, Helvécio Vinícius Antunes Rocha, Natália Neto Pereira Cerize, Maria Helena Ambrosio Zanin, Juliana Terzi Maricato, Valker Araujo Feitosa, Carlota de Oliveira Rangel-Yagui
RSC Pharm. 2026, 3, 552–563
 |
Are you ready to contribute to the future of pharmaceutics?
RSC Pharmaceutics publishes research on emerging technologies, including drug delivery, precision medicine and enhanced drug targeting, which have the potential to drive real change in health Led by Editor-in-Chief Yvonne Perrie, we are interested in papers that cover emerging technologies and techniques in pharmaceutics, including drug delivery, precision medicine, and enhanced drug targeting. If your research pushes the boundaries of current thinking, then we want to hear from you. As a gold Open Access journal, our publications are free to read, access and cite by anyone around the world. For authors, this means your publications have the potential to reach more people and make a greater impact. |
| Submit your manuscript | Read our publications | Follow us on social media |